Clinical Trial Update: Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update indicates that Avmacol ES is being studied in Phase 1/2 to prevent age-associated cardiac and vascular dysfunction, with recruitment ongoi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Dysfunction
• Heart Failure with Preserved Ejection Fraction
• Systolic Dysfunction

Drugs mentioned

• Avmacol ES

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Diastolic Dysfunction, Systolic Dysfunction | Phase 1, Phase 2 | Status: RECRUITING